We are currently leading two national studies, funded through the Moon Shot Initiative. The Institute is involved in prestigious
clinical trials to advance the science of pediatric tumor care, including T-cell immunotherapy and soon to be CAR T-cell studies. In addition, we are members of leading national and international pediatric brain tumor clinical consortia, including the Children’s Brain Tumor Tissue Network, Children’s Oncology Group’s Phase 1 Consortium, Collaborative Ependymoma Research Network,, Connect Consortium, Neurofibromatosis Clinical Trials Consortium (Department of Defense), Pacific / Pediatric Neuro-Oncology Consortium, Pediatric Brain Tumor Consortium and Remission (Immunotherapy) Consortium.